FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 46 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $81,869 | +81769.0% | 208,320 | -0.7% | 0.00% | – |
| Q4 2022 | $100 | -100.0% | 209,710 | -0.2% | 0.00% | – |
| Q3 2022 | $351,000 | +19.8% | 210,180 | +103.2% | 0.00% | – |
| Q2 2022 | $293,000 | -63.6% | 103,446 | -35.5% | 0.00% | – |
| Q1 2022 | $806,000 | -46.5% | 160,425 | +6.1% | 0.00% | – |
| Q4 2021 | $1,507,000 | -24.5% | 151,162 | -1.6% | 0.00% | – |
| Q3 2021 | $1,996,000 | +1.0% | 153,549 | +9.3% | 0.00% | – |
| Q2 2021 | $1,977,000 | – | 140,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |